(Press-News.org) NEW YORK (Nov. 3, 2010) -- Scientists at Weill Cornell Medical College have taken an important step toward a better understanding of prostate cancer by uncovering evidence that it is not one disease, as previously believed, but rather several factors which can be measured and, in the future, destroyed by targeted therapy.
The research team led by of Dr. Mark A. Rubin, the Homer T. Hirst Professor of Oncology in Pathology and vice chair for experimental pathology at Weill Cornell Medical College, identified secondary mutations that cause some types of prostate cancer cells to be lethal. The team believes that their discovery will lead to better tests for prostate cancer, sparing thousands of men from unnecessary biopsies, and leading to more specific and individualized therapy for prostate cancers that are likely to become deadly. The study results were published in the Oct. 29 online edition of the journal Genome Research.
The current research expands on the team's previous work with Arul M. Chinnaiyan's group at the University of Michigan that reported the first evidence that gene fusions, hybrid genes formed from two previously separate genes, play a widespread role in prostate cancer. At the time, it was known that gene fusions could drive the development of blood cancers but were only rarely detected in common solid cancers. Their finding was hailed as a landmark discovery by colleagues when it was first published in 2005 in the journal Science.
In their newly published work, Dr. Rubin and colleagues report evidence that gene fusion prostate cancers are susceptible to secondary mutations. This novel observation supports the view that aggressive cancers need to accumulate multiple mutations. Using discoveries made in this study, clinicians may be better able to diagnose and target potentially deadly tumors.
"In the future, these fusions, specific to certain types of prostate cancer, may help physicians prescribe tailored therapies for their patients," says Dr. Rubin. "This is an important step toward providing specific therapies that target individual cancer variants, and our hope is these findings will help doctors diagnose a patient's specific disease," explains Dr. Rubin.
Prostate cancer is the most common type of non-skin cancer found in American men and is the second leading cause of cancer death in men. According to the American Cancer Society, one in six men will get prostate cancer during his lifetime, and it will kill one in 36 men. The Society estimates that there will be about 217,730 new cases of prostate cancer and about 32,050 deaths in the United States this year.
Traditionally, screening for prostate cancer has been done by a blood test known as the Prostate Specific Antigen (PSA) test. However, it has not found to be as reliable as once thought. "PSA testing is inadequate. It detects men with cancer but also many men with benign conditions," according to Dr. Rubin. "As we have seen from two major studies on PSA screening, for every 100 men with a positive PSA screening, only 25 will have cancer."
Dr. Rubin's prior research has focused on a better understanding of prostate cancer and finding a test that will distinguish clinically significant prostate cancer from indolent disease that does not require additional treatment. Their research has led Dr. Rubin and his colleagues to co-develop the diagnostics for a new test for prostate cancer with the University of Michigan and two commercial partners, Gen-Probe and Ventana/Roche.
"The new test being developed will identify cells that are seen only in people with prostate cancer, allowing us to know with great certainty who has prostate cancer," according to Dr. Rubin. "This will result in fewer unnecessary biopsies, which have potential side effects, including infections, bloody semen, and rectal bleeding."
###Additional authors from Weill Cornell Medical College include Francesca Demichelis, Raquel Esgueva, Naoki Kitabayashi, Pei-Chun Lin, Theresa Y. MacDonald, Benjamin J. Moss, Dorothee Pflueger, David S. Rickman, Maria A. Svensson, Stéphane Terry and Ashutosh K. Tewari. Other authors included Mark B. Gerstein, Lukas Habegger and Andrea Sboner from Yale University, New Haven, Ct.; Terrence Barrette, Xuhong Cao and Arul M. Chinnaiyan from the University of Michigan, Ann Arbor, Mich.; and Mark S. Chee from Prognosys Biosciences, Inc., La Jolla, Calif.
Weill Cornell Medical College
Weill Cornell Medical College, Cornell University's medical school located in New York City, is committed to excellence in research, teaching, patient care and the advancement of the art and science of medicine, locally, nationally and globally. Physicians and scientists of Weill Cornell Medical College are engaged in cutting-edge research from bench to bedside, aimed at unlocking mysteries of the human body in health and sickness and toward developing new treatments and prevention strategies. In its commitment to global health and education, Weill Cornell has a strong presence in places such as Qatar, Tanzania, Haiti, Brazil, Austria and Turkey. Through the historic Weill Cornell Medical College in Qatar, the Medical College is the first in the U.S. to offer its M.D. degree overseas. Weill Cornell is the birthplace of many medical advances -- including the development of the Pap test for cervical cancer, the synthesis of penicillin, the first successful embryo-biopsy pregnancy and birth in the U.S., the first clinical trial of gene therapy for Parkinson's disease, and most recently, the world's first successful use of deep brain stimulation to treat a minimally conscious brain-injured patient. Weill Cornell Medical College is affiliated with NewYork-Presbyterian Hospital, where its faculty provides comprehensive patient care at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The Medical College is also affiliated with the Methodist Hospital in Houston, making Weill Cornell one of only two medical colleges in the country affiliated with two U.S.News & World Report Honor Roll hospitals. For more information, visit www.med.cornell.edu.
END
More than 30 million people in the United States travel to resource-limited areas of the world each year. This global mobility may contribute to the spread of infectious diseases – such as influenza, measles, and meningitis – and may also put individual travelers at risk for malaria, typhoid, dengue fever and hepatitis. Despite these potential risks, a recent study conducted by the Division of Infectious Diseases at Massachusetts General Hospital (MGH) and published in the Journal of Travel Medicine found that 46 percent of travelers to resource-limited countries did ...
NEW YORK (Nov. 3, 2010) -- Diffuse large B-cell lymphoma (DLBCL) is a type of aggressive non-Hodgkin's lymphoma that accounts for approximately 40 percent of lymphomas among adults. If left untreated, it is fatal. The existing treatments have a cure rate that is slightly over 50 percent but destroy healthy cells along with the cancer cells.
Researchers at Weill Cornell Medical College have found a combination therapy that is more effective than traditional treatments and is able to kill the cancer cells without harm to surrounding tissues. In a paper published in the ...
CINCINNATI—Researchers at the University of Cincinnati (UC) and the Cincinnati Veterans Affairs (VA) Medical Center have found that about one-third of chronic kidney disease patients who are prescribed therapies for high blood pressure do not often adhere to treatments.
This report was published in the Nov. 2 online edition of the American Journal of Nephrology.
The study, led by researchers at UC and the Cincinnati VA, showed that treatment of hypertension in patients with chronic kidney disease continues to be a challenge in their care and that by simply improving ...
Researchers at Mount Sinai School of Medicine have found that 98 percent of the U.S. population lives in communities within 60 minutes of a hospice provider, suggesting that disparities in use of hospice are not likely due to a lack of access to a hospice provider. The results are published in the current issue of the Journal of Palliative Medicine.
"Despite a significant increase in the availability of hospice services during the past decade, the majority of Americans die without hospice care," said Melissa D.A. Carlson, PhD, Assistant Professor of Geriatrics and Palliative ...
VIDEO:
Video opens with footage of a common cornstarch and water experiment. Ian Oberst, a visiting student from Portland Community College who participated in the University of Oregon's UCORE program for...
Click here for more information.
Mix two parts cornstarch and one part water. Swirl your fingers in it slowly and the mixture is a smoothly flowing liquid. Punch it quickly with your fist and you meet a rubbery solid -- so solid you can jump up and down on a vat of it.
It ...
Melt water flowing through ice sheets via crevasses, fractures and large drains called moulins can carry warmth into ice sheet interiors, greatly accelerating the thermal response of an ice sheet to climate change, according to a new study involving the University of Colorado at Boulder.
The new study showed ice sheets like the Greenland Ice Sheet can respond to such warming on the order of decades rather than the centuries projected by conventional thermal models. Ice flows more readily as it warms, so a warming climate can increase ice flows on ice sheets much faster ...
New Haven, Conn.—While sorting through hundreds of galaxy images as part of the Galaxy Zoo citizen science project two years ago, Dutch schoolteacher and volunteer astronomer Hanny van Arkel stumbled upon a strange-looking object that baffled professional astronomers. Two years later, a team led by Yale University researchers has discovered that the unique object represents a snapshot in time that reveals surprising clues about the life cycle of black holes.
In a new study, the team has confirmed that the unusual object, known as Hanny's Voorwerp (Hanny's "object" in ...
Positive psychological changes that occur during meditation training are associated with greater telomerase activity, according to researchers at the University of California, Davis, and the University of California, San Francisco. The study is the first to link positive well-being to higher telomerase, an enzyme important for the long-term health of cells in the body.
The effect appears to be attributable to psychological changes that increase a person's ability to cope with stress and maintain feelings of well-being.
"We have found that meditation promotes positive ...
LOS ALAMOS, New Mexico, NOVEMBER 3, 2010—Scientists at the U.S. Department of Energy's Los Alamos National Laboratory and Brookhaven National Laboratory have fabricated transparent thin films capable of absorbing light and generating electric charge over a relatively large area. The material, described in the journal Chemistry of Materials, could be used in development of transparent solar panels.
"Potentially, with future refinement of this technology, windows in a home or office could generate solar power," said Hsing-Lin Wang, a co-corresponding author of the paper ...
Older Americans are less healthy than their English counterparts, but they live as long or even longer than their English peers, according to a new study by researchers from the RAND Corporation and the Institute for Fiscal Studies in London.
Researchers found that while Americans aged 55 to 64 have higher rates of chronic diseases than their peers in England, they died at about the same rate. And Americans age 65 and older -- while still sicker than their English peers -- had a lower death rate than similar people in England, according to findings published in the journal ...
